About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Side effect(s) of Elapegademase-lvlr

Last Updated on May 11, 2022
Review the side-effects of Elapegademase-lvlr as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

The most common side effects of elapegademase-lvlr are



Cough and infections of the airways

Nausea and vomiting

Injection site reactions such as rashes, itching, pain, and swelling

Blood disorders (hemolytic anemia, neutropenia, abnormal levels of platelets)

Lymphomas or cancer of the lymphatic system

Other Precautions : Patients or the caregivers must be advised to take the elapegademase-lvlr therapy as suggested by the doctor and not stop or adjust the dose as it may affect the quality and the success of the treatment.

Drug Name : Elapegademase-lvlr

FDA approved elapegademase-lvlr injection for intramuscular use is used as an enzyme replacement therapy to treat adenosine deaminase severe combined immune deficiency (ADA-SCID) in children and adult patients.
More Info about Elapegademase-lvlr

Advertisement

DRUG-DRUG INTERACTIONS

Use this calculator if you are taking more than one drug
warning
Warning
If no interactions are found between two drugs, it does not necessarily mean that no interactions exist. Always consult with a healthcare professional.



Advertisement
Recommended Readings
Benefits of Registration
Advertisement
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close